2-氨基-4,6-二甲基嘧啶-5-羧酸乙酯 | 548773-06-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 中文名称: 2-氨基-4,6-二甲基嘧啶-5-羧酸乙酯
• 英文名称: ethyl 2-amino-4,6-dimethyl-pyrimidine-5-carboxylate
• 英文别名: Ethyl 2-amino-4,6-dimethylpyrimidine-5-carboxylate
• CAS: 548773-06-4
• 化学式: C₉H₁₃N₃O₂
• 分子量: 195.221
• InChiKey: IJOKURAJOZHAPR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  78.1
• 氢给体数：
  1
• 氢受体数：
  5

安全信息

• 海关编码：
  2933599090

反应信息

• 作为反应物：
  描述：

  2-氨基-4,6-二甲基嘧啶-5-羧酸乙酯 在 sodium hydroxide 作用下， 以 乙醇 为溶剂， 以100%的产率得到2-氨基-4,6-二甲基嘧啶-5-羧酸
  参考文献：
  名称：

  Oximino-piperidino-piperidine-based CCR5 antagonists. Part 2: synthesis, SAR and biological evaluation of symmetrical heteroaryl carboxamides

  摘要：

  The synthesis, SAR and biological evaluation of symmetrical amide analogues of our clinical candidate SCH 351125 are described. A series of potent and orally bioavailable CCR5 antagonists containing symmetrical 2,6-dimethyl isonicotinamides and 2, 6-dimethyl pyrimidines amides were generated with enhanced affinity for the CCR5 receptor. (C) 2003 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(02)01063-6
• 作为产物：
  描述：

  二乙酰乙酸乙酯 在 sodium ethanolate 、 caesium carbonate 作用下， 以 乙腈 为溶剂， 生成 2-氨基-4,6-二甲基嘧啶-5-羧酸乙酯
  参考文献：
  名称：

  Oximino-piperidino-piperidine-based CCR5 antagonists. Part 2: synthesis, SAR and biological evaluation of symmetrical heteroaryl carboxamides

  摘要：

  The synthesis, SAR and biological evaluation of symmetrical amide analogues of our clinical candidate SCH 351125 are described. A series of potent and orally bioavailable CCR5 antagonists containing symmetrical 2,6-dimethyl isonicotinamides and 2, 6-dimethyl pyrimidines amides were generated with enhanced affinity for the CCR5 receptor. (C) 2003 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(02)01063-6

文献信息

• [EN] MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS<br/>[FR] ANTIBIOTIQUES MACROCYCLIQUES À LARGE SPECTRE
  申请人：RQX PHARMACEUTICALS INC

  公开号：WO2017084630A1

  公开（公告）日：2017-05-26

  Provided herein are antibacterial compounds, wherein the compounds in some embodiments have broad spectrum bioactivity. In various embodiments, the compounds act by inhibition of bacterial type 1 signal peptidase (SpsB), an essential protein in bacteria. Pharmaceutical compositions and methods for treatment using the compounds described herein are also provided.

  本文提供了抗菌化合物，其中在某些实施例中，这些化合物具有广谱生物活性。在各种实施例中，这些化合物通过抑制细菌类型1信号肽酶（SpsB）发挥作用，这是细菌中的一种必需蛋白质。还提供了使用所述化合物的药物组合物和治疗方法。
• AZO METAL CHELATE DYE AND OPTICAL RECORDING MEDIUM
  申请人：Mitsubishi Kagaku Media Co., Ltd.

  公开号：EP2085430A1

  公开（公告）日：2009-08-05

  The invention provides an azo metal chelate dye suitable for use in a recording layer of an optical recording medium capable of high-speed recording or an optical recording medium having plural recording layers, and an optical recording medium. The azo metal chelate dye comprises an azo dye compound represented by general formula (1) and a metal: (wherein R1 represents a linear or branched alkyl group that may be substituted or a cycloalkyl group that may be substituted; R2 and R3 each independently represents a hydrogen atom, a linear or branched alkyl group that may be substituted, an aryl group that may be substituted, or a heterocyclic group that may be substituted; R4, R5, R6, R7, and R8 each independently represents a hydrogen atom or a linear or branched alky group that may be substituted, and R4 and R5, R4 and R6, or R5 and R7 may be bonded to each other to form a ring; Y represents a linear or branched alkyl group substituted with at least two fluorine atoms; and the chelate dye is constituted of the compound represented by general formula (1) from which a proton is released, and the metal).

  本发明提供了一种适用于高速记录或具有多个记录层的光记录介质的记录层中使用的偶氮金属螯合染料以及光记录介质。该偶氮金属螯合染料包括由通式（1）表示的偶氮染料化合物和金属：（其中R1表示可被取代的线性或支链烷基或可被取代的环烷基；R2和R3各自独立地表示氢原子、可被取代的线性或支链烷基、可被取代的芳基或可被取代的杂环基；R4、R5、R6、R7和R8各自独立地表示氢原子或可被取代的线性或支链烷基，且R4和R5、R4和R6或R5和R7可以相互结合形成环；Y表示至少带有两个氟原子的线性或支链烷基；螯合染料由通式（1）表示的从中释放质子的化合物和金属构成）。
• MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
  申请人：RQX PHARMACEUTICALS, INC.

  公开号：US20180327367A1

  公开（公告）日：2018-11-15

  Provided herein are antibacterial compounds, wherein the compounds in some embodiments have broad spectrum bioactivity. In various embodiments, the compounds act by inhibition of bacterial type 1 signal peptidase (SpsB), an essential protein in bacteria. Pharmaceutical compositions and methods for treatment using the compounds described herein are also provided.
• Oximino-piperidino-piperidine-based CCR5 antagonists. Part 2: synthesis, SAR and biological evaluation of symmetrical heteroaryl carboxamides
  作者：Anandan Palani、Sherry Shapiro、John W. Clader、William J. Greenlee、Susan Vice、Stuart McCombie、Kathleen Cox、Julie Strizki、Bahige M. Baroudy

  DOI：10.1016/s0960-894x(02)01063-6

  日期：2003.2

  The synthesis, SAR and biological evaluation of symmetrical amide analogues of our clinical candidate SCH 351125 are described. A series of potent and orally bioavailable CCR5 antagonists containing symmetrical 2,6-dimethyl isonicotinamides and 2, 6-dimethyl pyrimidines amides were generated with enhanced affinity for the CCR5 receptor. (C) 2003 Elsevier Science Ltd. All rights reserved.